866-997-4948 (US-Canada Toll Free)

Global MicroRNA Market 2012 - 2016

Published By :

Technavio

Published Date : 2013-09-27

Category :

Biotechnology

No. of Pages : 56

Product Synopsis


TechNavio's analysts forecast the Global MicroRNA market to grow at a CAGR of 17.51 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in microRNA research funding. The Global MicroRNA market has also been witnessing the discovery and development of microRNAs as biomarkers for diseases. However, the high R&D costs could pose a challenge to the growth of this market.

TechNavio's report, Global MicroRNA Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, and the ROW; it also covers the Global MicroRNA market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Alnylam Pharmaceuticals Inc., Exiqon A/S, and Santaris Pharma A/S.

Other vendors mentioned in the report are Access Pharmaceuticals, Aegera Therapeutics Inc., Affymetrix Inc., Agilent Technologies, Antisense Pharma GmbH, Aparna Biosciences Corp., Applied Biological Materials Inc., Arrowhead Research Corp., AstraZeneca Pharmaceuticals LP, Asuragen Inc., Benitec Biopharma Ltd., BioCancell Therapeutics Inc., Biogen Idec Inc., CBC Comprehensive Biomarker Center GmbH, Clontech Laboratories Inc., Dicerna Pharmaceuticals Inc., Eli Lilly and Co., EMD4Biosciences, Expression Genetics Inc., F. Hoffman-La Roche AG, Fluidigm Corp., GeneCopoeia Inc., GenoSensor Corp., Gensignia Inc., Groove Biopharma, GlaxoSmithKline, HTG Molecular Diagnostics Inc., Idera Pharmaceuticals Inc., Illumina Inc., InteRNA Technologies B.V., Isis Pharmaceuticals Inc., LC Sciences Llc, Life Technologies Corp., Merck & Co. Inc., miRagen Therapeutics Inc., Mirna Therapeutics Inc., NanoString Technologies Inc., Norgen Biotek Corp., Novartis AG, Pfizer Inc., Phalanx Biotech Group, PhaseRx Inc., Prolias Technologies Inc., Qiagen N.V., Quark Pharmaceuticals Inc., Regulus Therapeutics Inc., Rosetta Genomics Ltd., RXi Pharmaceuticals Corp., Sanofi U.S., Sarepta Therapeutics, Sigma-Aldrich Co. Llc, Silence Therapeutics Plc, Sirnaomics Inc., siRNAsense AS, Sylentis SA, Tacere Therapeutics Inc., Tekmira Pharmaceuticals Corp., Theradiag, Thermo Fisher Scientific Inc., and WaferGen Biosystems Inc.

Key questions answered in this report:

  • What will the market size be in 2016 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table Of Content

TABLE OF CONTENT

1. Executive Summary

2. Scope of the Report
2.1 Market Overview
2.2 Product Offerings

3. Market Research Methodology
3.1 Market Research Process
3.2 Research Design
3.3 Research Methodology

4. List of Abbreviations

5. Introduction

6. Market Landscape
6.1 Market Overview

7. Global MicroRNA Research Market

8. Global MicroRNA Market
8.1 Market Size and Forecast
8.2 Five Forces Analysis

9. Global MicroRNA Market Segmentation
9.1 Global MicroRNA Tools and Reagents Market
9.1.1 Market Size and Forecast
9.2 Global MicroRNA Therapeutics Market
9.2.1 Market Size and Forecast
9.3 Global MicroRNA Diagnostics Market
9.3.1 Market Size and Forecast

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.2 Key Vendor Ranking 2012
18.3 Other Prominent Vendors

19. Key Vendor Analysis
19.1 Alnylam Pharmaceuticals Inc.
19.1.1 Business Overview
19.1.2 Business Segmentation
19.1.3 Key Information
19.1.4 SWOT Analysis
19.2 Exiqon A/S
19.2.1 Business Overview
19.2.2 Business Segmentation
19.2.3 Key Information
19.2.4 SWOT Analysis
19.3 Santaris Pharma A/S
19.3.1 Business Overview
19.3.2 Business Segmentation
19.3.3 Key Information
19.3.4 SWOT Analysis

20. Other Reports in this Series

List of Tables

NA

List of Figures


Exhibit 1: Market Research Methodology
Exhibit 2: Market Segmentation
Exhibit 3: Market Segmentation by Geography
Exhibit 4: MicroRNA Research Publications
Exhibit 5: Models Employed for MicroRNA Research
Exhibit 6: Areas with MicroRNA Research
Exhibit 7: Global MicroRNA Market 2012-2016 (US$ million)
Exhibit 8: Global MicroRNA Market Segmentation
Exhibit 9: Global MicroRNA Market Segmentation 2012
Exhibit 10: Global MicroRNA Market Segmentation 2012-2016
Exhibit 11: Global MicroRNA Tools and Reagents Market 2012-2016 (US$ million)
Exhibit 12: Global MicroRNA Expression Profiling Market Segmentation by Type of Technology
Exhibit 13: Global MicroRNA Tools and Reagents Market Segmentation by Geography
Exhibit 14: Global MicroRNA Therapeutics Market 2012-2016 (US$ million)
Exhibit 15: Global MicroRNA Diagnostics Market 2012-2016 (US$ million)
Exhibit 16: Global MicroRNA Market Segmentation by Geography 2012
Exhibit 17: Business Segmentation of Alnylam Pharmaceuticals Inc.
Exhibit 18: Business segmentation of Exiqon A/S
Exhibit 19: Business Segmentation of Santaris Pharma A/S

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports

  • Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018

    By - Transparency

    The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those in later stage of development.  The vaccines market has become high revenue generators despite being priced at a premium because of increasing occurrences of acute diseases and growing elderly population. The vaccine market has captured the attention of big pharmaceutical companies...

  • Carbohydrase Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2013 - 2019

    By - Transparency

    Carbohydrase is a special type of enzyme that acts as a catalyst for breaking down the carbohydrates into simple sugar. Carbohydrase enzyme is mainly used to convert starch syrup into sugar syrup which is further used as an ingredient in the manufacturing of food and beverages and other applications. Carbohydrase enzymes are indigenously created in the body parts of human beings such as mouth, pancreas and small intestine. These enzymes are used for the digestion of carbohydrates by breaking down starch into sugars. Moreover, the carbohydrase enzymes are commercially produced for use...

  • Antithrombotic/Anticoagulant Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

    By - Transparency

    Antithrombotic is a drug that helps reduce thrombus formation. Different antithrombotics affect different blood clotting processes like antiplatelet drugs, anticoagulants, and thrombolytic drugs. Its main application is to treat the abnormal blood in the human body. Although antithrombotic drugs are widely used to prevent and treat arterial and venous thrombosis, the disease still remains one of the major reasons for deaths across the globe. This indicates that the present drugs available are not potent enough to deal with this hazardous disease. Hence, there is tremendous potential...